Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, and others. 2001. Botulinum toxin as a biological weapon: medical and public health management. J Am Med Assoc285: 1059-70.
2.
Borio L, Inglesby T, Peters CJ, Schmaljohn AL, Hughes JM, Jahrling PB, Ksiazek T, Johnson KM, Meyerhoff A, O’Toole T, and others. 2002. Hemorrhagic fever viruses as biological weapons: medical and public health management. J Am Med Assoc287: 2391-405.
3.
Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, and others. 2001. Tularemia as a biological weapon: medical and public health management. J Am Med Assoc285: 2763-73.
4.
Glass T, Schoch-Spana M. 2002. Bioterrorism and the public: how to vaccinate a city against panic. Clin Infectious Diseases34: 217-23.
5.
Henderson DA. 1999. The looming threat of bioterrorism. Science283: 1279-82.
6.
Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, Hauer J, Layton M, McDade J, Osterholm MT, and others. 1999. Smallpox as a biological weapon: medical and public health management. J Am Med Assoc281: 2127-37.
7.
Inglesby TV. 2002. Congressional testimony, the state of public health preparedness for terrorism involving weapons of mass destruction—a six month report card. U.S. Senate Committee on Government Affairs. Available from: http://www.hopkins-biodefense.org/pages/resources/tom.html. Accessed 2003 Jan 15.
8.
Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Koerner JF, and others. 2000a. Plague as a biological weapon: medical and public health management. J Am Med Assoc283: 2281-90.
9.
Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Hauer J, McDade J, Osterholm MT, O’Toole T, and others. 1999. Anthrax as a biological weapon: medical and public health management. J Am Med Assoc281: 1735-45.
10.
Inglesby TV, O’Toole T, Henderson, DA. 2000b. Addressing the challenge of biological weapons. Clin Infectious Diseases30: 926-9.
11.
Inglesby TV, O’Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Gerberding J, Hauer J, Hughes J, and others. 2002. Anthrax as a biological weapon, 2002: updated recommendations for management. J Am Med Assoc287: 2236-52.
12.
O’Toole T. 1999. Congressional testimony, hearing on terrorism preparedness: medical first response. House of Representatives Committee on Government Reform, Subcommittee on National Security, Veteran Affairs, and International Relations. Available from: http://www.hopkins-biodefense.org/pages/resources/prepare.html. Accessed 2003 Jan 15.
13.
O’Toole T. 2001. Congressional testimony, terrorism through the mail: protecting postal workers and the public (part II). U.S. Senate Committee on Government Affairs, Subcommittee on International Security, Proliferation and Federal Services. Available from: http://www.hopkins-biodefense.org/pages/resources/otoole.html. Accessed 2003 Jan 15.
14.
O’Toole T, Inglesby TV, Schoch-Spana M. 2000. Bioterrorism: national security threat, public health emergency. Unpublished manuscript.
15.
Radonovich, L. 2002. Hopkins center to launch clinicians’ biodefense network. Biodefense Quarterly [serial online]; 4: 1-2, 11. Available from: http://www.hopkins-biodefense.org/pages/news/pdf/quarter4_2.pdf. Accessed 2003 Jan 15.
16.
Smithson AE, Levy LA. 2000. Ataxia: the chemical and biological terrorism threat and the U.S. response. Washington (DC): Henry L. Stimson Center.
17.
Tucker JB. 1997. National health and medical services response to incidents of chemical and biological terrorism. J Am Med Assoc278: 362-8.
18.
Ursano B, Fullerton, CS, Norwood AE, editors. 2002. Responding to bioterrorism: individual and community needs. Bethesda (MD): Center for the Study of Traumatic Stress, Department of Psychiatry, Uniformed Services University of the Health Sciences.
